Capsular Contracture: Signs, Baker Grades and Treatment
Nearly every patient researching breast implants eventually meets the term “capsular contracture” — and for many it becomes the single biggest fear delaying the decision. The real picture is far more manageable than the internet horror stories suggest, but understanding it properly matters for both prevention and early recognition.
What the Capsule Is — and When It Becomes Contracture
The body forms a thin connective-tissue membrane around any implanted device — the capsule. This is universal and entirely normal. The problem is when that membrane thickens and tightens in some patients — contracture: it squeezes the implant, hardens the breast, and in advanced grades distorts shape and causes discomfort.
With modern implants and technique, clinically meaningful contracture runs at roughly 2–6% over ten years — the large majority of patients never experience it.
Baker Grades: Where Normal Ends
Grade I: the breast feels naturally soft — the goal. Grade II: mild firmness, normal appearance. Grade III: obvious firmness with visible shape change. Grade IV: hard, painful, visibly distorted.
The practical rule: Grades I–II are observed; Grades III–IV are candidates for surgical correction. Early postoperative tightness must not be confused with contracture — breasts are expected to soften over the first 3–6 months as tissues relax, not harden.
What Reduces the Risk
Evidence-based prevention: meticulous bloodless surgery, minimal-touch implant handling, the right pocket plane (submuscular/dual-plane placements show lower contracture rates), antibiotic irrigation, and sensible implant-to-tissue matching. Smoking and postoperative haematoma are established risk amplifiers.
For the wider decision, see our breast augmentation guide and the procedure page.
Treatment If It Develops
Early, mild presentations may simply be monitored. Established Grade III–IV cases have a well-defined surgical answer: capsulectomy, implant exchange, and frequently a change of pocket plane. In recurrent cases, polyurethane-coated implants offer markedly lower recurrence rates.
With properly planned revision, outcomes are good. Contracture is not “the end of implants” — it is a complication with a defined solution.